Paolo Fundaro - Director, Intercept Pharmaceuticals, Inc

As of June 1, 2021


Paolo Fundaro Net Worth

  • Net worth is estimated to be at least $212.03M
  • Owns at least 4,021,028 units of Intercept Pharmaceuticals, Inc stock
  • Sold an estimated value of $125.13M in the last 9 years at Intercept Pharmaceuticals, Inc

Paolo Fundaro Trading

  • Largest purchase of shares was 6,922 units , worth over $59.99K on February 14, 2014
  • Largest sale of shares was 1,500,000 units , worth over $71.25M on August 17, 2020
  • In total has made about 23 transactions over 9 years
  • Usually trades in June and May, with the busiest year in 2014
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Paolo Fundaro Mailing Address

  • Mailing address is C/o Genextra S.P.A., Via G. de Grassi, 11 Milan L6 20123 Italy

Intercept Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mark Pruzanski, M.D., 2020 $757,850 - $4,113,504 $1,015,996 $531,995 $7,660 $6,427,005
Mark Pruzanski, M.D., 2019 $734,292 - $4,197,742 $1,116,118 $560,265 $7,368 $6,615,785
Mark Pruzanski, M.D., 2018 $702,000 - $1,667,718 $1,705,358 $442,260 $8,623 $4,525,960
Jerome Durso, 2020 $599,524 - $2,057,016 $998,776 $231,737 $21,910 $3,908,963
Jerome Durso, 2019 $573,250 - $2,089,570 $1,238,321 $359,284 $21,368 $4,281,793
Jerome Durso, 2018 $540,800 - $1,554,326 $775,844 $292,032 $22,403 $3,185,406
Sandip Kapadia, 2020 $476,863 - $1,087,836 $528,088 $184,039 $21,910 $2,298,736
Sandip Kapadia, 2019 $464,100 - $1,001,664 $586,573 $252,935 $21,368 $2,326,640
Sandip Kapadia, 2018 $442,000 - $790,164 $393,544 $228,735 $22,403 $1,876,846
Richard Kim, 2020 $456,095 - $1,044,360 $505,128 $168,056 $79,211 $2,252,850
Richard Kim, 2019 $442,900 $202,800 $890,368 $521,398 $265,519 $76,343 $2,399,328
Lisa Bright, 2020 $480,552 - $925,704 $453,467 $240,955 $139,106 $2,239,784
Ryan Sullivan, 2020 $437,107 - $1,087,836 $528,088 - $89,942 $2,142,973
Ryan Sullivan, 2019 $445,520 - $1,471,902 $871,713 $267,089 $21,368 $3,077,592
Ryan Sullivan, 2018 $376,158 - $1,239,112 $1,190,351 $229,122 $173,437 $3,208,180
Christian Weyer, M.D., M.A.S., 2020 $486,731 - $925,704 $453,467 $170,804 $21,910 $2,058,616
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1270073/000110465921055639/tm218121-2_def14a.htm

Intercept Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 237,000 units bought on March 12, 2021 by Srinivas Akkaraju worth over $5.02M
  • In the last 9 years, insiders at Intercept Pharmaceuticals, Inc sold an estimated value of $1.66B and bought an estimated value of $148.73M
  • The most active traders are David Shapiro, Chief Medical Officer,  Mark Pruzanski, Director,  and Lisa Bright, President
  • Insider trading is most common in January, with the busiest year in 2019

INTERCEPT PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1